-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TGI-2 in Metastatic Melanoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TGI-2 in Metastatic MelanomaDrug Details:TGI-2 (NM1F) is under development for the treatment of advanced, or metastatic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TGI-2 in Solid Tumor
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TGI-2 in Solid TumorDrug Details:TGI-2 (NM1F) is under development for the treatment of advanced, or metastatic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TGI-2 in Metastatic Colorectal Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TGI-2 in Metastatic Colorectal CancerDrug Details:TGI-2 (NM1F) is under development for the treatment of advanced, or...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TGI-2 in Metastatic Ovarian Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TGI-2 in Metastatic Ovarian CancerDrug Details:TGI-2 (NM1F) is under development for the treatment of advanced, or...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TGI-2 in Triple-Negative Breast Cancer (TNBC)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TGI-2 in Triple-Negative Breast Cancer (TNBC)Drug Details:TGI-2 (NM1F) is under development for the treatment of advanced,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Dapagliflozin + Semaglutide) in Type 2 Diabetes
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.(Dapagliflozin + Semaglutide) in Type 2 DiabetesDrug Details:A fixed-dose combination of dapagliflozin and semaglutide is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AZD-7798 in Crohn’s Disease (Regional Enteritis)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.AZD-7798 in Crohn's Disease (Regional Enteritis) Drug Details:AZD-7798 is under development for the treatment of Crohn's...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Dapagliflozin + Semaglutide) in Type 2 Diabetes
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Dapagliflozin + Semaglutide) in Type 2 Diabetes Drug Details: A fixed-dose combination of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – O-304X in Diabetic Nephropathy
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.O-304X in Diabetic Nephropathy Drug Details:O-304X is under development for the treatment of heart failure with...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – RYZ-101 in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. RYZ-101 in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) Drug Details: RYZ-101 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PRT-1419 in Sarcomas
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.PRT-1419 in SarcomasDrug Details:PRT-1419 is under development for the treatment of solid tumors, sarcoma, melanoma, small...
-
Company Profile
![]()
Unbound Group Plc – Company Profile
Unbound Group Plc (Electra), formerly, Electra Private Equity PLC, is an investment trust focused on private equity. The company’s investment portfolio consists of buyouts and co-investments, funds, debt, and secondary investments. Electra invests across various sectors such as travel and leisure, media, house, and personal goods, private equity funds, support services, and real estate, among others. Electra mainly emphasizes the Western Europe region, particularly, in the UK. The company has investments in TGI Fridays, Sentinel Performance Solutions, buyout, Hotter Shoes,...
Add to Basket -
Product Insights
Cusiana–Bogota Pipeline, Colombia
Cusiana–Bogota is located in Casanare, Colombia. The pipeline is owned by Grupo Energia Bogota SA ESP (99.97%); Others (0.03%). It is operated by Transportadora de Gas Internacional TGI SA ESP. The project started its operations in 1995. Cusiana–Bogota Pipeline profile includes core details such as name, location (start and end points and route points), pipeline type, asset status, start year, owner and equity stakes, operator, length, diameter, design pressure and installed capacity along with relevant news, deals and contracts details....
-
Product Insights
Cusiana–La Belleza Pipeline, Colombia
Cusiana–La Belleza is located in Casanare, Colombia. The pipeline is owned by Grupo Energia Bogota SA ESP (99.97%); Others (0.03%). It is operated by Transportadora de Gas Internacional TGI SA ESP. The project started its operations in 2003. Cusiana–La Belleza Pipeline profile includes core details such as name, location (start and end points and route points), pipeline type, asset status, start year, owner and equity stakes, operator, length, diameter, design pressure and installed capacity along with relevant news, deals and...
-
Product Insights
Ballena–Barrancabermeja Pipeline, Colombia
Ballena–Barrancabermeja is located in La Guajira, Colombia. The pipeline is owned by Grupo Energia Bogota SA ESP (99.97%); Others (0.03%). It is operated by Transportadora de Gas Internacional TGI SA ESP. The project started its operations in 1996. Ballena–Barrancabermeja Pipeline profile includes core details such as name, location (start and end points and route points), pipeline type, asset status, start year, owner and equity stakes, operator, length, diameter, design pressure and installed capacity along with relevant news, deals and contracts...
-
Product Insights
Mariquita–Cali Pipeline, Colombia
Mariquita–Cali is located in Tolima, Colombia. The pipeline is owned by Grupo Energia Bogota SA ESP (99.97%); Others (0.03%). It is operated by Transportadora de Gas Internacional TGI SA ESP. The project started its operations in 1997. Mariquita–Cali Pipeline profile includes core details such as name, location (start and end points and route points), pipeline type, asset status, start year, owner and equity stakes, operator, length, diameter, design pressure and installed capacity along with relevant news, deals and contracts details....
-
Product Insights
Barrancabermeja–Neiva Pipeline, Colombia
Barrancabermeja–Neiva is located in Santander, Colombia. The pipeline is owned by Grupo Energia Bogota SA ESP (99.97%); Others (0.03%). It is operated by Transportadora de Gas Internacional TGI SA ESP. Barrancabermeja–Neiva Pipeline profile includes core details such as name, location (start and end points and route points), pipeline type, asset status, start year, owner and equity stakes, operator, length, diameter, design pressure and installed capacity along with relevant news, deals and contracts details. This is an on-demand report that will...
-
Sector Analysis
Consumer and Market Insights: Prepared Meals in the US
Strong economic conditions and high disposable incomes of consumers are driving the Prepared Meals market in the US. The market is being led by the Ready Meals category while Meal Kits is forecast to register fastest growth in value terms during 2015-2020. Hypermarkets & Supermarkets account for the highest distribution share for Prepared Meals in the country. Nestle S.A., General Mills, Inc. and Pinnacle Foods, Inc. are the leading players in the market.
-
Sector Analysis
Ireland – The Future of Foodservice to 2020
"Ireland - The Future of Foodservice to 2020", published by GlobalData, provides extensive insight and analysis of the Republic of Ireland's foodservice market over the next five years (2015-2020) and acts as a vital point of reference for operators or suppliers. The Irish foodservice profit sector is forecast to continue experiencing weak to moderate sales value growth, at a stable CAGR of 1.4% to 2020. Despite the country's promising economic recovery and falling unemployment, weak transaction growth and stagnant outlet...
-
Sector Analysis
Global Dairy Food Market: Merger and Acquisitions January 2016
Using this report, dealmakers will effectively gain an insight into deal activity of the global dairy food market throughout the month. Additionally, the report provides an overview of all the partnering, alliances, and M&A deals announced worldwide. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of deal activity in the global dairy food market on a monthly basis.
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.